Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / Induzione di Invasive Transitional cellulare…
JoVE Journal
Medicine

A subscription to JoVE is required to view this content.
You will only be able to see the first 2 minutes.

JoVE Journal Medicine
Induzione di Invasive Transitional cellulare Bladder Carcinoma in immunitario intatto umani MUC1 topi transgenici
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Journal (Medicine)
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Journal (Medicine)
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
 
Click here for the English version

Induzione di Invasive Transitional cellulare Bladder Carcinoma in immunitario intatto umani MUC1 topi transgenici: un modello di sviluppo Immunoterapia

Article DOI: 10.3791/50868 • 11:02 min
October 30th, 2013 •
1, 1, 2, 1, 1, 1, 3, 1
1Department of Internal Medicine, Division of Hematology and Oncology, University of California, Davis, 2Comparative Pathology Laboratory, UC Davis School of Veterinary Medicine, University of California, Davis, 3Merck Serono Research, Merck KGaA, Darmstadt, Germany

Chapters

Summary
Automatic Translation
October 30th, 2013

Please note that all translations are automatically generated.

Click here for the English version.

Un N-butil-N-(4-idrossibutil) nitrosamine indotta modello di cancro alla vescica è stato sviluppato in mucina umano 1 (MUC1) topi transgenici per la fine del controllo MUC1-diretto immunoterapia. Dopo la somministrazione di un vaccino peptidico MUC1-mirata, una risposta di linfociti T citotossici per MUC1 è stata confermata misurando i livelli sierici di citochine e l'attività delle cellule T specifiche.

Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter